{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:59:19Z","timestamp":1770062359015,"version":"3.49.0"},"reference-count":51,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:00:00Z","timestamp":1757203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272321"],"award-info":[{"award-number":["82272321"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hepatitis B virus (HBV) infection remains a significant global health burden, primarily due to its chronic complications, including acute exacerbation, cirrhosis, hepatocellular carcinoma (HCC), and related sequelae. Acute exacerbation of chronic hepatitis B (CHB-AE) is common and often represents the earliest clinical manifestation. The Hepatitis B virus X protein (HBx) (17-kDa) is not only essential for viral replication but also plays a role in the development of HCC. To investigate the role of HBx mutation in CHB-AE progression, we enrolled 33 hospitalized CHB-AE patients and 31 patients with HBV-related liver failure (controls) from mainland China between January 2017 and June 2018. Single mutation 36 of HBx was significantly more prevalent in CHB-AE patients (p &lt; 0.05), whereas Joint Mutation 1 was more frequent in HBV-related liver failure patients (p &lt; 0.05). HBx mutations, including Single mutation 36 and Joint Mutations 2 and 3, were significantly associated with high HBV DNA levels (p &lt; 0.05), while Joint mutation 1 predominated in the low HBV DNA group (p &lt; 0.01). Age-stratified analysis showed that Single mutation 36 and Joint Mutation 2 were more common in younger patients (&lt;35 years old) (p &lt; 0.05), whereas Joint mutation 1 was more frequent in older age (\u226535 years old) (p &lt; 0.05). Moreover, antiviral therapy markedly reduced the prevalence of Joint mutation 1 from 82.98% in treatment-na\u00efve patients to 29.41% in treatment-experienced patients (p &lt; 0.0001). These findings suggest that specific HBx mutations are associated with viral replication levels, disease progression, and patient demographics. Such mutations may serve as molecular markers for disease severity and potential therapeutic targets in both CHB-AE and HBV-related liver failure.<\/jats:p>","DOI":"10.3390\/v17091223","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:06:32Z","timestamp":1757318792000},"page":"1223","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of HBx Mutations in Chronic Hepatitis B with Acute Exacerbation"],"prefix":"10.3390","volume":"17","author":[{"given":"Xiaobei","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, East Campus, Renmin Hospital of Wuhan University, Wuhan 430223, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzhi","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, East Campus, Renmin Hospital of Wuhan University, Wuhan 430223, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0545-0439","authenticated-orcid":false,"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology and Biosafety, Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyun","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, East Campus, Renmin Hospital of Wuhan University, Wuhan 430223, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Fever Clinic, East Campus, Renmin Hospital of Wuhan University, Wuhan 430223, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Fever Clinic, East Campus, Renmin Hospital of Wuhan University, Wuhan 430223, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7378-443X","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Fever Clinic, East Campus, Renmin Hospital of Wuhan University, Wuhan 430223, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7031-2956","authenticated-orcid":false,"given":"Fan","family":"Zhu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology and Biosafety, Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China"},{"name":"Hubei Province Key Laboratory of Allergy & Immunology, Wuhan University, Wuhan 430071, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,7]]},"reference":[{"key":"ref_1","unstructured":"WHO (2024, April 09). Hepatitis B. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chang, M.L., and Liaw, Y.F. (2022). Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031552"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"28126","DOI":"10.3390\/ijms161226087","article-title":"Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation","volume":"16","author":"Tsai","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_5","first-page":"521","article-title":"Acute exacerbation and superinfection in patients with chronic viral hepatitis","volume":"94","author":"Liaw","year":"1995","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3350\/cmh.2019.0060","article-title":"The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?","volume":"26","author":"Lall","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jhep.2014.08.033","article-title":"Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management","volume":"61","author":"Chang","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1440-1746.2009.05924.x","article-title":"Severe acute exacerbation of chronic hepatitis B: A unique presentation of a common disease","volume":"24","author":"Wong","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: A 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/JHC.S307962","article-title":"The Mechanisms of HBV-Induced Hepatocellular Carcinoma","volume":"8","author":"Jiang","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: Viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s12072-020-10116-z","article-title":"HBx mutations emerged during antiviral therapy: A new face of a multifaceted HBV protein?","volume":"14","author":"Zhou","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1349-7006.2006.00299.x","article-title":"Molecular functions and biological roles of hepatitis B virus x protein","volume":"97","author":"Tang","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-9378-7-27","article-title":"The viral transactivator HBx protein exhibits a high potential for regulation via phosphorylation through an evolutionarily conserved mechanism","volume":"7","author":"Venegas","year":"2012","journal-title":"Infect. Agent. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1128\/JVI.78.23.12725-12734.2004","article-title":"The enigmatic X gene of hepatitis B virus","volume":"78","author":"Bouchard","year":"2004","journal-title":"J. Virol."},{"key":"ref_17","first-page":"75","article-title":"Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis","volume":"103","author":"Benhenda","year":"2009","journal-title":"Adv. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Schollmeier, A., Glitscher, M., and Hildt, E. (2023). Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054964"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/abbs\/gmr048","article-title":"The role of hepatitis B virus X protein is related to its differential intracellular localization","volume":"43","author":"Ma","year":"2011","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coviro.2018.01.007","article-title":"Role of HBx in hepatitis B virus persistence and its therapeutic implications","volume":"30","author":"Slagle","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1038\/sj.onc.1203903","article-title":"Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma","volume":"19","author":"Yeh","year":"2000","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcv.2005.01.006","article-title":"Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma","volume":"34","author":"Chen","year":"2005","journal-title":"J. Clin. Virol."},{"key":"ref_23","first-page":"OC31","article-title":"Mutations in Hepatitis-B X-Gene Region: Chronic Hepatitis-B versus Cirrhosis","volume":"11","author":"Salarnia","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.micpath.2019.01.004","article-title":"Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma","volume":"128","author":"Chaturvedi","year":"2019","journal-title":"Microb. Pathog."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jhep.2017.07.011","article-title":"How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?","volume":"67","author":"Rajoriya","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2174\/1566524021666210816094412","article-title":"The association between hepatitis B Virus mutations and the risk of liver disease and hepatocellular carcinoma","volume":"22","author":"Akrami","year":"2022","journal-title":"Curr. Mol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1093\/nar\/11.13.4601","article-title":"Cloning and structural analyses of hepatitis B virus DNAs, subtype adr","volume":"11","author":"Fujiyama","year":"1983","journal-title":"Nucleic Acids Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.14218\/JCTH.2016.00019","article-title":"Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)","volume":"5","author":"Hou","year":"2017","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_29","unstructured":"Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, and Chinese Medical Association (2013). Diagnostic and treatment guidelines for liver failure (2012 version). Zhonghua Gan Zang Bing Za Zhi, 21, 177\u2013183."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1128\/JVI.80.9.4406-4414.2006","article-title":"Activation of focal adhesion kinase by hepatitis B virus HBx protein: Multiple functions in viral replication","volume":"80","author":"Bouchard","year":"2006","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"105115","DOI":"10.18632\/oncotarget.22428","article-title":"Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients","volume":"8","author":"Nazir","year":"2017","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0923-2516(06)80047-6","article-title":"The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C","volume":"144","author":"Luber","year":"1993","journal-title":"Res. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1038\/s41467-024-52201-z","article-title":"USP26 as a hepatitis B virus-induced deubiquitinase primes hepatocellular carcinogenesis by epigenetic remodeling","volume":"15","author":"Ma","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Damme, E.V., Vanhove, J., Severyn, B., Verschueren, L., and Pauwels, F. (2021). The Hepatitis B Virus Interactome: A Comprehensive Overview. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.724877"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"He, T., Zhang, N., Wang, L., Wan, B.S., Wang, X.Q., and Zhang, L. (2020). GPR43 regulates HBV X protein (HBx)-induced inflammatory response in human LO2 hepatocytes. Biomed. Pharmacother., 123.","DOI":"10.1016\/j.biopha.2019.109737"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zhang, D., Guo, S.C., and Schrodi, S.J. (2021). Mechanisms of DNA Methylation in Virus-Host Interaction in Hepatitis B Infection: Pathogenesis and Oncogenetic Properties. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189858"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Rizzo, G.E.M., Cabibbo, G., and Crax\u00ec, A. (2022). Hepatitis B Virus-Associated Hepatocellular Carcinoma. Viruses, 14.","DOI":"10.3390\/v14050986"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1128\/MCB.21.22.7721-7730.2001","article-title":"Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress","volume":"21","author":"Waris","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B Virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1099\/vir.0.019224-0","article-title":"HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice","volume":"91","author":"Tsuge","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1128\/jvi.67.3.1218-1226.1993","article-title":"The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks","volume":"67","author":"Chen","year":"1993","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1128\/jvi.68.3.2026-2030.1994","article-title":"Woodchuck hepatitis virus X protein is required for viral infection in vivo","volume":"68","author":"Zoulim","year":"1994","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/djn243","article-title":"REVEAL-HBV Study Group: Associations between hepatitis B virus genotype and mutations and the risk of hepatocellular carcinoma","volume":"100","author":"Yang","year":"2008","journal-title":"J. Nat Cancer Inst."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/jvh.13318","article-title":"HBV variants are common in the \u2018immune-tolerant\u2019 phase of chronic hepatitis B","volume":"27","author":"Yuen","year":"2020","journal-title":"J. Viral. Hepat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3892\/mco.2016.847","article-title":"HBV X gene point mutations are associated with the risk of hepatocellular carcinoma: A systematic review and meta-analysis","volume":"4","author":"Wang","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s12072-020-10079-1","article-title":"Hepatitis B virus X gene mutants emerge during antiviral therapy and increase cccDNA levels to compensate for replication suppression","volume":"14","author":"Lin","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1128\/JVI.79.9.5548-5556.2005","article-title":"The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication","volume":"79","author":"Tang","year":"2005","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/HEP.0000000000000752","article-title":"Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients","volume":"80","author":"Choi","year":"2024","journal-title":"Hepatology"},{"key":"ref_49","unstructured":"Chinese Society of Hepatology, and Chinese Medical Association (2022). Expert opinion on expanding anti-HBV treatment for chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi, 30, 131\u2013136."},{"key":"ref_50","first-page":"1425","article-title":"Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)","volume":"11","author":"You","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/HEP.0000000000000496","article-title":"Editorial: Reassessing antiviral treatment criteria for chronic hepatitis B","volume":"78","author":"Lok","year":"2023","journal-title":"Hepatology"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/9\/1223\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:07:08Z","timestamp":1770023228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/9\/1223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,7]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["v17091223"],"URL":"https:\/\/doi.org\/10.3390\/v17091223","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,7]]}}}